The rs1447295 at 8q24 Is a Risk Variant for Prostate Cancer in Taiwanese Men

Urology

Volumn 74, Issue 3, 2009, Pages 698-701

  Chen, Marcelo ^a,b,c   Huang, Yu Chuen ^d   Ko, I ling ^e   Yang, Stone ^b,c   Chang, Yen Hwa ^f   Huang, William Ji Shian ^f   Chen, Yi Ming Arthur ^e  

^a Georgetown Univ School of Medicine   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c Mackay Medicine   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TAIWAN;

AGED; ALLELES; CASE-CONTROL STUDIES; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; TAIWAN;

EID: 69249220339     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.02.035     Document Type: Article

References (18)

1. Gronberg H. Prostate cancer epidemiology. Lancet 361 (2003) 859-864
2. Department of Health. Executive Yuan, ROC (Taiwan). Summary of statistics on causes of death in Taiwan, 2007.
3. Hsing A.W., and Chokkalingam A.P. Prostate cancer epidemiology. Front Biosci 11 (2006) 1388-1413
4. Amundadottir L.T., Sulem P., Gudmundsson J., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 28 (2006) 652-658
5. Freedman M.L., Haiman C.A., Patterson N., et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103 (2006) 14068-14073
6. Gudmundsson J., Sulem P., Manolescu A., et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 39 (2007) 631-637
7. Haiman C.A., Patterson N., Freedman M.L., et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 38 (2007) 638-644
8. Yeager M., Orr N., Hayes R.B., et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39 (2007) 645-649
9. Robbins C., Torres J.B., Hooker S., et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 17 (2007) 1717-1722
10. Terada N., Tsuchiya N., Ma Z., et al. Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population. Prostate 68 (2008) 1689-1695
11. Suuriniemi M., Agalliu I., Schaid D.J., et al. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 16 (2007) 809-814
12. Cheng I., Plummer S.J., Jorgenson E., et al. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet 16 (2008) 496-505
13. Wang L., McDonnell S.K., Slusser J.P., et al. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 67 (2007) 2944-2950
14. Zheng S.L., Sun J., Cheng Y., et al. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans. J Natl Cancer Inst 99 (2007) 1525-1533
15. Helfand B.T., Loeb S., Cashy J., et al. Tumor characteristics of carriers and noncarriers of the decode 8q24 prostate cancer susceptibility alleles. J Urol 179 (2008) 2197-2202
16. Sun J., Chang B.L., Isaacs S.D., et al. Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. Prostate 68 (2008) 1257-1262
17. Severi G., Hayes V.M., Padilla E.J., et al. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev 16 (2007) 610-612
18. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level less than or equal to 4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246